Morphological and functional alterations in the substantia nigra pars compacta of the Mecp2-null mouse
@article{Panayotis2011MorphologicalAF, title={Morphological and functional alterations in the substantia nigra pars compacta of the Mecp2-null mouse}, author={Nicolas Panayotis and M. Pratte and Ana Borges-Correia and A. Ghata and J. Roux}, journal={Neurobiology of Disease}, year={2011}, volume={41}, pages={385-397} }
Rett syndrome (RTT) is a severe neurological disorder caused by mutations in the MECP2 gene, in which older patients often develop parkinsonian features. Although Mecp2 has been shown to modulate the catecholaminergic metabolism of the RTT mouse model, little is known about the central dopaminergic neurons. Here we found that the progression of the motor dysfunction in the Mecp2-deficient mouse becomes more severe between 4 and 9 weeks of age. We then studied the phenotype of the dopaminergic… CONTINUE READING
43 Citations
Loss of Mecp2 in Substantia Nigra Dopamine Neurons Compromises the Nigrostriatal Pathway
- Biology, Medicine
- The Journal of Neuroscience
- 2011
- 38
- Highly Influenced
- PDF
MeCP2-mediated alterations of striatal features accompany psychomotor deficits in a mouse model of Rett syndrome
- Biology, Medicine
- Brain Structure and Function
- 2013
- 24
- Highly Influenced
- PDF
Altered trajectories of neurodevelopment and behavior in mouse models of Rett syndrome
- Biology, Medicine
- Neurobiology of Learning and Memory
- 2019
- 8
Improvement of the Rett Syndrome Phenotype in a Mecp2 Mouse Model Upon Treatment with Levodopa and a Dopa-Decarboxylase Inhibitor
- Biology, Medicine
- Neuropsychopharmacology
- 2014
- 14
- Highly Influenced
- PDF
Biogenic amines and their metabolites are differentially affected in the Mecp2-deficient mouse brain
- Biology, Medicine
- BMC Neuroscience
- 2011
- 30
Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient mice.
- Biology, Medicine
- Human molecular genetics
- 2013
- 24
- PDF
Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway
- Biology, Medicine
- Neurobiology of Disease
- 2012
- 52
Are dopamine receptor and transporter changes in Rett syndrome reflected in Mecp2-deficient mice?
- Medicine
- Experimental Neurology
- 2018
- 5
- PDF
Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome
- Biology, Medicine
- Neurobiology of Disease
- 2014
- 81
References
SHOWING 1-10 OF 62 REFERENCES
Pathophysiology of Locus Ceruleus Neurons in a Mouse Model of Rett Syndrome
- Biology, Medicine
- The Journal of Neuroscience
- 2009
- 111
- PDF
Progressive noradrenergic deficits in the locus coeruleus of Mecp2 deficient mice
- Biology, Medicine
- Journal of neuroscience research
- 2010
- 38
Widespread changes in dendritic and axonal morphology in Mecp2‐mutant mouse models of rett syndrome: Evidence for disruption of neuronal networks
- Biology, Medicine
- The Journal of comparative neurology
- 2009
- 221
- PDF
Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome
- Medicine
- The European journal of neuroscience
- 2007
- 124
- PDF
Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice
- Biology, Medicine
- Proceedings of the National Academy of Sciences
- 2006
- 137
- PDF
Mecp2 Deficiency Disrupts Norepinephrine and Respiratory Systems in Mice
- Biology, Medicine
- The Journal of Neuroscience
- 2005
- 253
- PDF
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
- Biology, Medicine
- Nature Genetics
- 2001
- 1,397
- PDF
Progressive Loss of Dopaminergic Neurons in the Ventral Midbrain of Adult Mice Heterozygote for Engrailed1
- Biology, Medicine
- The Journal of Neuroscience
- 2007
- 144
- PDF
Evidence for abnormal early development in a mouse model of Rett syndrome
- Psychology, Medicine
- Genes, brain, and behavior
- 2007
- 82